UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

249 ACCURATE PERSONALIZATION OF PEG-IFN+RBV TREATMENT DURATION BASED ON THE DECLINE OF HCV INFECTED CELLS COMPUTED DURING THE 1ST MONTH OF THERAPY

Journal of hepatology, 2010-04, Vol.52, p.S105-S105

2010

Volltextzugriff (PDF)

3 IMPROVED IN VITRO HBV REPLICATION IN HuH7 CELL LINE TRANSFECTED WITH FULL LENGTH CIRCULAR CLOSED HBV DNA BY MODIFICATIONS OF THE GUNTHER'S METHOD

Digestive and liver disease, 2010, Vol.42, p.S2-S2

2010

Volltextzugriff (PDF)

639 MODELLING INFECTED CELL DYNAMICS BY WEEK 4 HCV RNA AND ALT KINETICS ALLOWS FOR INDIVIDUAL TAILORING OF TREATMENT DURATION IN CHRONIC HEPATITIS C PATIENTS

Journal of hepatology, 2009, Vol.50, p.S235-S235

2009

Volltextzugriff (PDF)

F.N.37 ACCURATE INDIVIDUALIZATION OF PEG-IFN+RBV TREATMENT DURATION BY HCV INFECTED CELL DECLINE COMPUTED IN THE 1ST MONTH OF THERAPY

Digestive and liver disease, 2010-02, Vol.42, p.S46-S47

2010

Volltextzugriff (PDF)

646 THE CONTROL OF HBV REPLICATION THAT LEADS TO HBEAG LOSS DOES NOT PREVENT THE EMERGENCE OF PRE-CORE DEFECTIVE VARIANTS IN GENOTYPE D INFECTED CHILDREN

Journal of hepatology, 2008, Vol.48, p.S241-S241

2008

Volltextzugriff (PDF)

Modelling infected cell dynamics by week 4 HCV RNA and ALT kinetics to compute treatment duration

Digestive and liver disease, 2009, Vol.41 (3), p.A31-A31

2009

Volltextzugriff (PDF)

The candidate HCV E1E2MF59 vaccine enhances 2nd phase viral decline in responders to PEG-IFN/ribavirin

Digestive and liver disease, 2009, Vol.41 (3), p.A19-A19

2009

Volltextzugriff (PDF)

249 ACCURATE PERSONALIZATION OF PEG-IFN+RBV TREATMENT DURATION BASED ON THE DECLINE OF HCV INFECTED CELLS COMPUTED DURING THE 1 ST MONTH OF THERAPY

Journal of hepatology, 2010, Vol.52, p.S105-S105

2010

Volltextzugriff (PDF)

Clinical and molecular characterization of chronic hepatitis B in Albania: A country that is still highly endemic for HBV infection

Journal of medical virology, 2005-01, Vol.75 (1), p.20-26

2005

Volltextzugriff (PDF)

F.N.37 ACCURATE INDIVIDUALIZATION OF PEG-IFN+RBV TREATMENT DURATION BY HCV INFECTED CELL DECLINE COMPUTED IN THE 1 ST MONTH OF THERAPY

Digestive and liver disease, 2010, Vol.42, p.S46-S47

2010

Volltextzugriff (PDF)

Early prediction of sustained response in chronic hepatitis C patients treated with pegilated IFNs (A-2B or A-2A) plus ribavirin using a bio-mathematical model that describes the dynamics of infected cells

Digestive and liver disease, 2006-04, Vol.38, p.S29-S29

2006

Volltextzugriff (PDF)

Early HCV-RNA kinetics after liver transplantation correlate with the outcome of recurrent hepatitis C

Journal of hepatology, 2003-04, Vol.38, p.37-37

2003

Volltextzugriff (PDF)

Diagnosis and monitoring of hepatitis virus infection in liver transplant patients

Transplantation proceedings, 2003-05, Vol.35 (3), p.1025-1027

2003

Volltextzugriff (PDF)

28 Early HCV-RNA kinetics after liver transplantation correlates with the outcome of recurrent hepatitis C

Digestive and liver disease, 2003-02, Vol.35, p.A9-A9

2003

Volltextzugriff (PDF)

Monitoring HCV-RNA levels during the first month of treatment identifies primary responders to interferon

Journal of hepatology, 1998, Vol.28, p.191-191

1998

Volltextzugriff (PDF)

Optimization of functional performance of additively manufactured cobalt‑chromium‑molybdenum alloy for dental implant applications

Journal of manufacturing processes, 2024-06, Vol.120, p.1087-1103

2024

Volltextzugriff (PDF)

Status and challenges for sustainable billfish fisheries in the Western Indian Ocean

Reviews in fish biology and fisheries, 2022-12, Vol.32 (4), p.1035-1061

2022

Volltextzugriff (PDF)

A novel variant in COX16 causes cytochrome c oxidase deficiency, severe fatal neonatal lactic acidosis, encephalopathy, cardiomyopathy, and liver dysfunction

Human mutation, 2021-02, Vol.42 (2), p.135-141

2021

Volltextzugriff (PDF)

Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana

Medicine (Baltimore), 2019-02, Vol.98 (6), p.e14313

2019

Volltextzugriff (PDF)

REDUCED ORDER TOPOLOGY OPTIMISATION OF A PLANAR HONEYCOMB DEFINED BY A LINEAR ELASTIC Ti6Al4V (ELI) MATERIAL MODEL

South African journal of industrial engineering, 2022-11, Vol.32 (3), p.299-317

2022

Volltextzugriff (PDF)

Gene identification and comparative molecular modeling of a Trypanosoma rangeli major surface protease

Journal of molecular modeling, 2013-08, Vol.19 (8), p.3053-3064

2013

Volltextzugriff (PDF)

Assessments of Cranial Capacities in a North-Eastern Adult Nigerian Population

Journal of applied sciences (Asian Network for Scientific Information), 2011-07, Vol.11 (14), p.2662-2665

2011

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

249 ACCURATE PERSONALIZATION OF PEG-IFN+RBV TREATMENT DURATION BASED ON THE DECLINE OF HCV INFECTED CELLS COMPUTED DURING THE 1ST MONTH OF THERAPY

3 IMPROVED IN VITRO HBV REPLICATION IN HuH7 CELL LINE TRANSFECTED WITH FULL LENGTH CIRCULAR CLOSED HBV DNA BY MODIFICATIONS OF THE GUNTHER'S METHOD

639 MODELLING INFECTED CELL DYNAMICS BY WEEK 4 HCV RNA AND ALT KINETICS ALLOWS FOR INDIVIDUAL TAILORING OF TREATMENT DURATION IN CHRONIC HEPATITIS C PATIENTS

F.N.37 ACCURATE INDIVIDUALIZATION OF PEG-IFN+RBV TREATMENT DURATION BY HCV INFECTED CELL DECLINE COMPUTED IN THE 1ST MONTH OF THERAPY

646 THE CONTROL OF HBV REPLICATION THAT LEADS TO HBEAG LOSS DOES NOT PREVENT THE EMERGENCE OF PRE-CORE DEFECTIVE VARIANTS IN GENOTYPE D INFECTED CHILDREN

Modelling infected cell dynamics by week 4 HCV RNA and ALT kinetics to compute treatment duration

The candidate HCV E1E2MF59 vaccine enhances 2nd phase viral decline in responders to PEG-IFN/ribavirin

249 ACCURATE PERSONALIZATION OF PEG-IFN+RBV TREATMENT DURATION BASED ON THE DECLINE OF HCV INFECTED CELLS COMPUTED DURING THE 1 ST MONTH OF THERAPY

Clinical and molecular characterization of chronic hepatitis B in Albania: A country that is still highly endemic for HBV infection

F.N.37 ACCURATE INDIVIDUALIZATION OF PEG-IFN+RBV TREATMENT DURATION BY HCV INFECTED CELL DECLINE COMPUTED IN THE 1 ST MONTH OF THERAPY

Early prediction of sustained response in chronic hepatitis C patients treated with pegilated IFNs (A-2B or A-2A) plus ribavirin using a bio-mathematical model that describes the dynamics of infected cells

Early HCV-RNA kinetics after liver transplantation correlate with the outcome of recurrent hepatitis C

Diagnosis and monitoring of hepatitis virus infection in liver transplant patients

28 Early HCV-RNA kinetics after liver transplantation correlates with the outcome of recurrent hepatitis C

Monitoring HCV-RNA levels during the first month of treatment identifies primary responders to interferon

Optimization of functional performance of additively manufactured cobalt‑chromium‑molybdenum alloy for dental implant applications

Status and challenges for sustainable billfish fisheries in the Western Indian Ocean

A novel variant in COX16 causes cytochrome c oxidase deficiency, severe fatal neonatal lactic acidosis, encephalopathy, cardiomyopathy, and liver dysfunction

Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana

REDUCED ORDER TOPOLOGY OPTIMISATION OF A PLANAR HONEYCOMB DEFINED BY A LINEAR ELASTIC Ti6Al4V (ELI) MATERIAL MODEL

Gene identification and comparative molecular modeling of a Trypanosoma rangeli major surface protease

Assessments of Cranial Capacities in a North-Eastern Adult Nigerian Population

Suchergebnisse filtern